在CAR-T细胞治疗后发生的眼部不良事件:药监测研究和系统性审查
Connor Frey1, Hannah Cherniawsky2, Mahyar Etminan3
1Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
European journal of haematology
|March 29, 2024
概括
化学抗原受体T细胞 (CAR-T) 疗法对血液癌症有前途,但可能导致报告不足的眼部不良事件. 眼科医生和瘤学家必须预测这些副作用,以管理患者的发病率.
科学领域:
- 在瘤学瘤学.
- 眼科医生 眼科 眼科
- 免疫治疗是一种免疫疗法.
背景情况:
- 免疫瘤学,特别是仿真抗原受体T细胞 (CAR-T) 疗法,在治疗血液恶性瘤方面取得了重大进展.
- 与CAR-T细胞疗法相关的眼部不良事件报告不足,需要进一步调查.
结论:
- 卡特-T细胞治疗与需要临床关注的特定眼部不良事件有关.
- 眼科医生和瘤学家应警潜在的眼部副作用,以减轻患者的发病率.
更多相关视频
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.3K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.3K
相关概念视频
01:19Pharmacovigilance
830
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
830
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K